Resources Investment Advisors, Llc. Halozyme Therapeutics, Inc. Transaction History
Resources Investment Advisors, Llc.
- $8.93 Billion
- Q3 2025
A detailed history of Resources Investment Advisors, Llc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Resources Investment Advisors, Llc. holds 8,950 shares of HALO stock, worth $637,150. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,950
Previous 9,136
2.04%
Holding current value
$637,150
Previous $475,000
38.11%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding HALO
# of Institutions
648Shares Held
156MCall Options Held
408KPut Options Held
366K-
Dld Asset Management, LP New York, NY30MShares$2.14 Billion10.67% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$1.25 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$828 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$423 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.29MShares$234 Million0.16% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.92B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...